Revenue
$131.9m
+5.1% ↑ vs $125.5m
Operating EBITDA was nearly flat but operating cash flow fell 44% and gross borrowings rose 34% to $1.0bn against a subdued property market.
Revenue context before the current result.
EBITDA margin across covered periods.
Operating cash flow across covered periods.
Operating working-capital absorption or release by reporting period.
Key metrics
HY26 vs HY25
Revenue
$131.9m
+5.1% ↑ vs $125.5m
EBITDA
$43.7m
-0.9% ↓ vs $44.1m
Net profit after tax
−$8.2m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Net cash inflow from operating activities
$44.7m
-43.7% ↓ vs $79.5m
Profit before tax
−$8m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Cash and cash equivalents
$5.1m
+32.6% ↑ vs $3.9m
Total assets
$4.7b
+9.5% ↑ vs $4.3b
What changed
Net cash inflow from operating activities fell 43.7% to $44.7m from $79.5m, taking cash conversion (OCF/EBITDA) from 180.3% to 102.3%. Gross borrowings rose 33.9% to $1b, lifting net debt to roughly $1b and net debt/EBITDA (on annualised half-year EBITDA) to about 23.5x from 17.4x.
The headline swing from a $64.0m profit to an $8.2m loss is largely an investment-property revaluation effect: HY25 included a $72.9m fair value gain on investment property, while the current half ran without that tailwind against the "subdued" property market management noted in commentary. This is also Arvida's first half-year reporting as a debt-only issuer following the issuer transition.
What matters
OCF/EBITDA fell from 180.3% to 102.3% even though EBITDA was essentially flat. The $34.8m year-on-year shortfall in operating cash reflects ORA settlement and working-capital timing rather than a profit shortfall, but it lands at a moment when the debt stack has grown materially. Cash to service that larger stack came in well below the comparable.
Leverage trajectory. Gross borrowings rose $260.5m while equity rose only $31.2m on a 9.5% larger asset base. The headline 23.5x net debt/EBITDA looks extreme but is partly an artefact of how EBITDA excludes resale and revaluation contributions in this sector; the directional move from 17.4x is what matters, particularly for a debt-only issuer where covenant headroom drives flexibility.
Underlying operating engine is steady. Revenue +5.1% on growth in deferred management fees and care/village services, with resale settlements 4% higher than HY25. Stripping out fair value movements, the recurring earnings base is broadly flat — the dramatic NPAT line is doing more work than the operating read warrants.
Expectations
The FY25 shape shows H1 represented 49.5% of full-year revenue but only 43.7% of full-year Operating EBITDA — second-half weighted, with implied H2 FY25 EBITDA of $56.9m versus $44.1m in H1.
If the FY25 cadence repeats, full-year Operating EBITDA could again approach $100m. But reported NPAT is unlikely to benefit from a repeat of HY25's $72.9m fair value tailwind given the "subdued" property market commentary, so the reported earnings shape and the operating earnings shape will likely diverge again at year-end.
Quality of result
Revenue growth came from deferred management fees and care/village service revenues — durable, recurring streams — and receivable days improved to 25.6 from 29.4. But operating cash flow at $44.7m is sharply below the $79.5m comparable, and FCF (pre-lease) of $40.8m against a -$8.2m NPAT yields a -499.1% conversion that is not informative this half. Capex of $3.9m, just 3.0% of revenue, is light and likely reflects timing rather than a structural step-down.
The reported NPAT loss is overwhelmingly an accounting effect. The 2.0pp gap between PBT growth (-114.8%) and NPAT growth (-112.8%) is small, so this is not a tax distortion — it is the absence of the prior fair value gain on investment property flowing through both PBT and NPAT. The operating read sits with EBITDA, not the headline loss line, but the cash and leverage trajectory is the more economically material development this half.
Unresolved
This briefing cannot assess covenant headroom, refinancing terms, or the specific fair value movement on investment property without those disclosures.
Chat
Ask follow-up questions about Arvida Group's HY26 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load analytical metrics.
Open to load key metrics.
Interim Report
HY26 / financial reportMedia Release
HY26 / media releaseResults Announcement
HY26 / results announcementInterim Report
HY25 / financial reportMedia Release
HY25 / media releaseResults Announcement
HY25 / results announcementArvida Group Limited - 2025 Consolidated Financial Statements (Audited)
FY25 / financial reportFY25 Results Announcement (NZX Prescribed Release)
FY25 / results announcementFY25 Results Market Release
FY25 / results releaseRelated insights
Cross-company views selected from the metrics in this briefing.
Cash conversion quality
This result converted 102.3% of EBITDA to operating cash flow, -77.9pp versus the prior comparable period.
Leverage and balance-sheet risk
Net debt / EBITDA is 23.46x, +6.10x versus the prior comparable period.
Earnings quality and statutory distortions
This result includes a statutory earnings-quality distortion flag.
Revenue growth context
Revenue growth was 5.1% for this reporting period.
Get the next Arvida Group briefing and related NZX reporting-season updates by email.